0001013762-23-002552.txt : 20231006
0001013762-23-002552.hdr.sgml : 20231006
20231006163246
ACCESSION NUMBER: 0001013762-23-002552
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230801
FILED AS OF DATE: 20231006
DATE AS OF CHANGE: 20231006
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Abildgaard Ole
CENTRAL INDEX KEY: 0001994976
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38758
FILM NUMBER: 231314586
MAIL ADDRESS:
STREET 1: VEDBAEK STRANDVEJ 506
CITY: VEDBAEK
STATE: G7
ZIP: 2950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RENOVARO BIOSCIENCES INC.
CENTRAL INDEX KEY: 0001527728
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452259340
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: CENTURY CITY MEDICAL PLAZA
STREET 2: 2080 CENTURY CITY EAST
CITY: SUITE 906 LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 45 39179840
MAIL ADDRESS:
STREET 1: CENTURY CITY MEDICAL PLAZA
STREET 2: 2080 CENTURY CITY EAST
CITY: SUITE 906 LOS ANGELES
STATE: CA
ZIP: 90067
FORMER COMPANY:
FORMER CONFORMED NAME: Enochian Biosciences Inc.
DATE OF NAME CHANGE: 20230804
FORMER COMPANY:
FORMER CONFORMED NAME: Renovaro Biosciences Inc.
DATE OF NAME CHANGE: 20230802
FORMER COMPANY:
FORMER CONFORMED NAME: Enochian Biosciences Inc
DATE OF NAME CHANGE: 20180306
3
1
ownership.xml
X0206
3
2023-08-01
0
0001527728
RENOVARO BIOSCIENCES INC.
RENB
0001994976
Abildgaard Ole
VEDBAEK STRANDVEJ 506
VEDBAEK
G7
2970
DENMARK
0
0
1
0
Common Stock
3462292
I
By Paseco ApS
Common Stock
5000
D
Series A Convertible Preferred Stock
0
2023-08-01
Common Stock
3436190
I
By Paseco ApS
Warrants (right to buy)
1.14
2023-03-29
2028-03-29
Common Stock
125000
I
By Paseco ApS
Warrants (right to buy)
0.53
2023-06-26
2028-06-26
Common Stock
1415870
I
By Paseco ApS
Warrants (right to buy)
0.65
2023-08-01
2028-08-01
Common Stock
1718095
I
By Paseco ApS
The Series A Convertible Preferred Stock ("Preferred Stock") is convertible into Common Stock on a one-for-ten basis and has no expiration date
Ole Abildgaard, as Chief Executive Officer and sole shareholder of Paseco ApS, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
/s/ Ole Abildgaard
2023-10-06